| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |